There are 449 resources available
From the current status to unmet needs
Presenter: Martin Reck
Session: Seagen - Moving forward in metastatic NSCLC: The role of ADCs
Resources:
Webcast
ADCs in late-stage development: Who can benefit?
Presenter: Enriqueta Felip
Session: Seagen - Moving forward in metastatic NSCLC: The role of ADCs
Resources:
Webcast
When tissue is the issue: Optimising rapid liquid biopsy testing in NSCLC
Presenter: Fernando Lopez-Rios
Session: Thermo Fisher Scientific - The critical role of timely genomic profiling in NSCLC
Resources:
Webcast
Beyond the horizon: Unveiling novel ADC targets
Presenter: Anna Minchom
Session: Seagen - Moving forward in metastatic NSCLC: The role of ADCs
Resources:
Webcast
Insights from in-house: evaluating the impact of ultra-fast NGS on patient outcomes
Presenter: Morten Grauslund
Session: Thermo Fisher Scientific - The critical role of timely genomic profiling in NSCLC
Resources:
Webcast
Panel discussion and audience Q&A
Session: Seagen - Moving forward in metastatic NSCLC: The role of ADCs
Resources:
Webcast
Q&A and panel discussion
Session: Thermo Fisher Scientific - The critical role of timely genomic profiling in NSCLC
Resources:
Webcast
Closing remarks
Presenter: Martin Reck
Session: Seagen - Moving forward in metastatic NSCLC: The role of ADCs
Resources:
Webcast
Closing remarks
Presenter: Fernando Lopez-Rios
Session: Thermo Fisher Scientific - The critical role of timely genomic profiling in NSCLC
Resources:
Webcast
Current diagnostic standards for NSCLC: Clinical implications
Presenter: Keith Kerr
Session: Advancing molecular diagnosis in lung cancer
Resources:
Slides
Webcast